sarcoma of the extremity Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1/2 (1)

Interventional (1)

University of Washington (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadct scan

I am/have/hadwhite blood cell count

I am/have/hadbone metastases

I am/have/hadneutrophil count

I am/have/hadsoft tissue sarcoma

I am/have/hadmetastasis

I am/have/hadprimary tumor

I am/have/hadserum pregnancy test

I am/have/hadblood transfusion

I am/have/hadhair thinning

I am/have/hadsarcoma

I am/have/hadgilbert's syndrome

I am/have/hadhuman chorionic gonadotropin

added new label for I am/have/had

more

I am looking for

I am looking forhuman chorionic gonadotropin

I am looking fororal contraceptives

I am looking forcolony-stimulating factors

I am looking forg-csf

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities

This phase I/II trial studies the side effects and best dose of cabozantinib when given with radiation therapy and how well it works in treating patients with sarcoma of the extremities. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving …

ct scan

white blood cell count

bone metastases

neutrophil count

soft tissue sarcoma

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.